Research advances on related molecules and genes affecting the efficacy of gemcitabine for pancreatic cancer
10.3760/cma.j.issn.1006-9801.2012.07.026
- VernacularTitle:影响吉西他滨治疗胰腺癌疗效的相关分子和基因的研究进展
- Author:
Hao LIN
- Publication Type:Journal Article
- Keywords:
Pancreatic neoplasms;
Gemcitabine;
Genes;
Molecular mechanisms of action
- From:
Cancer Research and Clinic
2012;24(7):501-504
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatic cancer normally is lethal and difficult to treat.Recently,although chemotherapy drugs such as gemcitabine for the treatment achieved a certain effect, but the survival rate has not improved significantly. Over the past decade, a large number of studies that aimed to implicated in pancreatic tumor gemcitabine metabolism and resistance mechanisms. Recent data show that it is a great value for predicting efficacy in the treatment of pancreatic cancer with gemcitabine by detecting pancreatic cancer -related molecules and genes, especially in the field of individual therapy. This review describes advances in the studies of related molecules and genes affecting the efficacy of gemcitabine for pancreatic cancer.
